Catalyst
Slingshot members are tracking this event:
European Commission Grants Marketing Authorization for Gilead’s Single Tablet Regimen Odefsey (Emtricitabine, Rilpivirine, Tenofovir Alafenamide) for the Treatment of HIV
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| GILD |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jun 23, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Odefsey, Emtricitabine, Rilpivirine, Tenofovir Alafena, Hiv
